Fumaric Acid

Fumaric Acid

SCHEMBL6875

O=C(O)C=CC(=O)O.O=C(O)C=CC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 2/20 0.43
MEN1 known ✓ O00255 1/20 0.43
TSHR P16473 4/20 1.00
TP53 P04637 1/20 1.00
EGLN1 Q9GZT9 1/20 1.00
EGLN3 Q9H6Z9 1/20 1.00
HCAR2 Q8TDS4 4/20 0.53
GABRR1 P24046 2/20 0.47
GABRR2 P28476 2/20 0.47
BLM P54132 2/20 0.47
LMNA P02545 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
GABRR3 A8MPY1 1/20 0.47
APEX1 P27695 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALDH1A1 P00352 3/20 0.45
GAA P10253 1/20 0.45
ALOX15 P16050 1/20 0.45
RECQL P46063 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL650322 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL2046433 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL623596 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL3998225 1.00
Maleic Acid SCHEMBL613 1.00
Maleic Acid SCHEMBL20487516 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL2046432 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL2046430 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL615 1.00
Fumaric Acid SCHEMBL1331192 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2323 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024096708-A1 NOVEL CRYSTALLINE FORM OF A PYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND METHODS OF USE THEREOF HANMI PHARM. CO., LTD. (KR) 2024-05-10 WO claimed
WO-2024018394-A1 A PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM A OF N, N'-BIS(2-AMINOETHYL)-1,2-ETHANEDIAMINE TETRAHYDROCHLORIDE BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) 2024-01-25 WO claimed
US-20240000935-A1 ANTIGEN SPECIFIC T CELLS AND METHODS OF MAKING AND USING SAME GENEIUS BIOTECHNOLOGY, INC. (US) 2024-01-04 US claimed
WO-2024003797-A1 CRYSTALLINE SALTS OF LISDEXAMFETAMINE IND-SWIFT LABORATORIES LIMITED (IN) 2024-01-04 WO claimed
EP-4251177-A2 ANTIGEN SPECIFIC T CELLS AND METHODS OF MAKING AND USING SAME Geneius Biotechnology, Inc. (US) 2023-10-04 EP claimed
WO-2023143486-A1 SALT, CRYSTALLINE FORM, SOLVATE AND HYDRATE OF COMPOUND 深圳众格生物科技有限公司 2023-08-03 WO claimed
CN-115677675-A Salt of 6-oxaspiro [4,5] decane compound, preparation method and application 成都苑东生物制药股份有限公司 2023-02-03 CN claimed
EP-2437684-B1 ANTERIOR SEGMENT DRUG DELIVERY FORSIGHT VISION5 INC (US) 2022-06-15 EP claimed
WO-2022115641-A2 ANTIGEN SPECIFIC T CELLS AND METHODS OF MAKING AND USING SAME GENEIUS BIOTECHNOLOGY, INC. (US) 2022-06-02 WO claimed
US-20220117989-A1 COMPOSITIONS AND METHODS FOR INDUCING OR SUPPLEMENTING SOCS3 TO ABROGATE TUMOR GROWTH AND PROLIFERATIVE RETINOPATHY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-04-21 US claimed
US-4840991-A ADDITION POLYMERS FOR COATINGS DESOTO, INC. (US) 1989-06-20 US claimed
US-4839403-A DISPERSION OF EPOXY PHOSPHATE SALT, CURING AGENT AND HYDROXY-CONTAINING ACRYLIC POLYMER DESOTO, INC. (US) 1989-06-13 US claimed
EP-0268913-A2 Aqueous dispersions of partially cross-linked emulsion copolymers DeSoto, Inc. (US) 1988-06-01 EP claimed
EP-0111588-B1 PHYSICALLY-AMELIORATED STYRENE POLYMER/THERMOPLASTIC ELASTOMER POLYBLENDS THE DOW CHEMICAL COMPANY (US) 1987-09-09 EP claimed
EP-0092479-B1 N,N'-SUBSTITUTED POLYMETHYLENE DIAMINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR (FR) 1986-01-29 EP claimed
EP-0090733-B1 DISUBSTITUTED POLYMETHYLENE IMINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR (FR) 1985-10-30 EP claimed
US-4514398-A Disubstituted polymethylene imines ADIR (FR) 1985-04-30 US claimed
US-4514399-A N-N'substituted polymethylene diamines ADIR (FR) 1985-04-30 US claimed
EP-0092479-A1 N,N'-substituted polymethylene diamines, processes for their preparation and pharmaceutical compositions containing them ADIR (FR) 1983-10-26 EP claimed
EP-0090733-A1 Disubstituted polymethylene imines, processes for their preparation and pharmaceutical compositions containing them ADIR (FR) 1983-10-05 EP claimed